Low testosterone in ageing men: a modifiable risk factor for frailty?

Trends Endocrinol Metab

Andrology Research Unit, Developmental and Regenerative Biomedicine Research Group, Manchester Academic Health Science Centre (MAHSC), The University of Manchester, Manchester Royal Infirmary, Manchester M13 9WL, UK.

Published: December 2011

There is substantial interest in the role of testosterone (T) in male ageing. Studies suggest that low T may be a risk factor for frailty, the vulnerable health status that occurs at advanced ages. However, T deficiency is relatively rare in ageing men and, importantly, is linked to modifiable risk factors including body weight and concurrent illnesses. These observations shift the focus away from hormone replacement and towards potential preventative strategies to help maintain T levels in ageing men. Furthermore, the effects of T on physical function remain inconsistent, and studies examining the safety of T treatment in ageing males raise concerns. Further research may usefully focus on novel pro-anabolic pharmaceutical agents, which together with other interventions will allow for optimal management of frailty.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tem.2011.08.003DOI Listing

Publication Analysis

Top Keywords

ageing men
12
modifiable risk
8
risk factor
8
ageing
5
low testosterone
4
testosterone ageing
4
men modifiable
4
factor frailty?
4
frailty? substantial
4
substantial interest
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!